The current valuation score of Soleno Therapeutics Inc is 6.81, ranking 206 out of 382 in the Biotechnology & Medical Research industry. Its current P/E ratio is 27.14, which is 384.22% below the recent high of 131.42 and 211.16% above the recent low of -30.17.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.